(Q43039569)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17657816%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

title

Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17657816%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17657816%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

12

Hiromitsu Kumada

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17657816%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

2

Fumitaka Suzuki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17657816%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

11

Kenji Ikeda

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17657816%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

8

Masahiro Kobayashi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17657816%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

6

Yoshiyuki Suzuki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17657816%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1

Norio Akuta

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17657816%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

10

Yasuji Arase

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17657816%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

5

Hitomi Sezaki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17657816%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

3

Yusuke Kawamura

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17657816%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

9

Mariko Kobayashi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17657816%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Hiromi Yatsuji

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17657816%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

language of work or name

English

0 references

publication date

1 November 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17657816%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17657816%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17657816%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17657816%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

1357-1364

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17657816%20AND%20SRC:MED&resulttype=core&format=json

Prognosis of chronic hepatitis C: results of a large, prospective cohort study.

2 January 2020

cites work

1 reference

The natural course of chronic hepatitis C: implications for clinical practice

21 January 2018

1 reference

Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients

21 January 2018

1 reference

Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group

21 January 2018

1 reference

Risk factors of hepatitis C virus-related liver cirrhosis in young adults: positive family history of liver disease and transporter associated with antigen processing 2(TAP2)*0201 Allele

21 January 2018

1 reference

Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy.

21 January 2018

1 reference

Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.

21 January 2018

1 reference

Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: amino acid substitutions in the core region and low-density lipoprotein cholest

21 January 2018

1 reference

Long-term follow-up of interferon monotherapy in 454 consecutive naive patients infected with hepatitis C virus: multi-course interferon therapy may reduce the risk of hepatocellular carcinoma and increase survival

21 January 2018

1 reference

Molecular basis of hepatitis C virus-associated hepatocarcinogenesis: lessons from animal model studies

21 January 2018

1 reference

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

21 January 2018

1 reference

A nucleotide sequence variation detection system for the core region of hepatitis C virus-1b

21 January 2018

1 reference

Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis

21 January 2018

1 reference

Proteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core protein

21 January 2018

1 reference

Critical role of PA28 in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis

21 January 2018

1 reference

Identification of Hepatitis C Virus (HCV) Subtype 1b Strains That Are Highly, or Only Weakly, Associated with Hepatocellular Carcinoma on the Basis of the Secondary Structure of an Amino-Terminal Portion of the HCV NS3 Protein

21 January 2018

1 reference

High amino acid variability within the NS5A of hepatitis C virus (HCV) is associated with hepatocellular carcinoma in patients with HCV-1b-related cirrhosis.

21 January 2018

1 reference

Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis.

21 January 2018

1 reference

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

21 January 2018

1 reference

7 January 2021

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

7 January 2021

Genotypic subtyping of hepatitis C virus

1 reference

7 January 2021

Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in an advanced stage: a retrospective study in 1148 patients. Viral Hepatitis Therapy Study Group

1 reference

7 January 2021

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

1 reference

7 January 2021

Interferon retreatment reduces or delays the incidence of hepatocellular carcinoma in patients with chronic hepatitis C

1 reference

7 January 2021